Major Depressive Disorder Excellence Forum

Major Depressive Disorder

Excellence Forum

Videos

Addressing Depression Symptoms With a Comprehensive Approach

08/06/2023

Ahmed Baig , MD;

Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.

Ahmed Baig, MD, Chief Medical...

08/06/2023

Psych Congress Network

Videos

Novel Treatments for MDD and TRD

08/03/2023

Ahmed Baig , MD;

Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.

Ahmed Baig, MD, Chief Medical...

08/03/2023

Psych Congress Network

Susan Montgomery, DNP, FNP-BC, and Lauren Sharp, FNP

Videos

Routine Depression Screening Increases Identification, Diagnosis, and Management: Part 2

08/01/2023

Susan Mongomery, DNP, FNP-BC, and Lauren Sharp, FNP, share more about findings from their study “Improving Screening for Major Depressive Disorder."

Susan Mongomery, DNP, FNP-BC,...

08/01/2023

Psych Congress Network

Why are clinicians wary of antipsychotic use in MDD treatment?

Expert Insights Quiz

Why do clinicians tend to underuse antipsychotics in the treatment of MDD?

07/27/2023

Craig Chepke , MD, DFAPA;

Time for a pop quiz!

07/27/2023

Psych Congress Network

Videos

Why Antipsychotics Are Underutilized for Major Depressive Disorder (MDD)

07/25/2023

Craig Chepke , MD, DFAPA;

Craig Chepke, MD, DFAPA, shares why he thinks clinicians do not use antipsychotics for MDD treatment as much as they could.

Craig Chepke, MD, DFAPA, shares...

07/25/2023

Psych Congress Network

Pop quiz written on a blackboard with white chalk

Expert Insights Quiz

How can clinicians optimize treatment with subcutaneous racemic ketamine for TRD?

07/25/2023

Put your psychiatry knowledge to the test with this quiz!

Put your psychiatry knowledge to...

07/25/2023

Psych Congress Network

Expert Insights Quiz

How many patients accepted depression treatment following diagnosis?

07/22/2023

Test your knowledge!

07/22/2023

Psych Congress Network

Q&As

Ketamine Treatment in TRD Should Last 4 Weeks or More for Antidepressant Benefit

07/21/2023

Colleen Loo , MBBS, MD;

Colleen Loo, MBBS, FRANZCP, MD, lead researcher of a groundbreaking study on the use of subcutaneous racemic ketamine for TRD, shares the rationale behind the study, its major findings, practical implications, and more.

Colleen Loo, MBBS, FRANZCP, MD,...

07/21/2023

Psych Congress Network

Videos

Routine Depression Screening Increases Identification, Diagnosis, and Management: Part 1

07/21/2023

Susan Mongomery, DNP, FNP-BC, and Lauren Sharp, FNP, discuss findings from their study “Improving Screening for Major Depressive Disorder."

Susan Mongomery, DNP, FNP-BC,...

07/21/2023

Psych Congress Network

Expert Insights Quiz

Who saw the most improvement in depressive symptoms after physical activity?

07/17/2023

Was it children older or younger than 13 years?

Was it children older or younger...

07/17/2023

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Major Depressive Disorder Excellence Forum

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products